ARB-ArborGen Holdings Ltd

[TheHunter]

Mr Ralph, I'm curious as to why you think it's time to sell (the opposite view from myself). Always good to challenge one's own logic and hear the opposing side.

[biker]

Yelp dubya 10.5% today time to sell me thinks

I think that over the last two decades they talk about, of any time, now is actually the best time to buy not sell.
Hindsight is seductive but I have a lot of these and have had for far too long. Wish I was buying now, not many years ago.
Certainly not selling with current performance and prospects. At last we are getting a whiff of more sustainable and growing earnings.

imho

[percy]

I think that over the last two decades they talk about, of any time, now is actually the best time to buy not sell.
Hindsight is seductive but I have a lot of these and have had for far too long. Wish I was buying now, not many years ago.
Certainly not selling with current performance and prospects. At last we are getting a whiff of more sustainable and growing earnings.

imho

I agree with you after reading their announcement and looking at their chart.

[ralph]

Mr Ralph, I'm curious as to why you think it's time to sell (the opposite view from myself). Always good to challenge one's own logic and hear the opposing side.

All depends on your motives if your profits are up 50% as some will be it may be time sell & reinvest elsewhere and see higher growth over the short term .
I am not opposing the potential positive's for arborgen I think its happy days for the shareholders , just looking at maximizing the potential it may well go from 50% up to 100% & who knows what's around the corner do you!

[percy]

https://farmersweekly.us19.list-mana...2&e=4c7f670243

[biker]

A long time since we’ve seen a positive article like that. Thanks Percy.

[biker]

Paper-thin volume but good to see 20c again.

[biker]

Looks like the last announcement lit the boiler and created enough steam to at least start to move the train out of the station. Buyers ( and sellers) at .235 this morning.
Not holding my breath but the best optics for quite a while.

[winner69]

Seems like our big pay day / get out of jail card is just around the corner

Hope directors don’t stuff it up

[biker]

ArborGen Announces Strategic Review
30/6/2021, 9:15 am MKTUPDTE
30 June 2021 - Global advanced genetics seedling company, ArborGen Holdings Limited (NZX:ARB) (ArborGen or the Company) advises that the Company has received a confidential, non‐binding, indicative, incomplete and highly conditional proposal from a credible third party to acquire all of the shares in, or assets of, ArborGen by way of a scheme of arrangement or other alternative acquisition structure (the Proposal). A sub-committee of independent directors of ArborGen was appointed to assess the Proposal (the Sub-Committee) and has concluded that, based on the information currently before the Sub-Committee, the Proposal materially undervalues the Company. In light of this, the Board has decided to commence a strategic review. The objective of the strategic review is to consider all options to unlock value for the benefit of all shareholders. These options could include (but are not limited to) a potential sale of all of the shares in, or all or some of the assets of the Company, or a US listing.

ArborGen is the largest commercial global seedling supplier and a leading provider of advanced genetics, for the forest industry. Employing state-of-the-art technology, ArborGen is developing high-value products that significantly improve the productivity of a given acre of land by enabling our customers to grow trees that yield more wood per acre with greater consistency and quality in a shorter period of time.

It specialises in loblolly pine (US and Brazil), radiata pine (New Zealand and Australia) and eucalyptus (Brazil and Australia) plantation forestry species. It has 18 seedling nurseries, 12 seed producing orchards and overall production capacity of 540 million seedlings annually globally.

As set out in the 27 May 2021 market announcement (https://www.nzx.com/announcements/372976), ArborGen’s 2021 financial results outlined a significantly improved outlook for the company driven primarily by increased availability of its proprietary MCP seedlings in the US.

With increased availability of proprietary advanced genetic products (MCP seedlings) in the US, improving markets in all regions, and increased demand for proprietary genetics, ArborGen believes that it is now well positioned for accelerated growth.

PwC has been engaged to assist ArborGen in undertaking the strategic review.

There is no certainty that any transaction or other change will result from the strategic review.

ENDS